Table 2.
Experimental Groups | [Ca2+]i, nM | n |
---|---|---|
Control | 101 ± 2 | 6 |
ANG-(1–7) (10−12 M) | 252 ± 8* | 5 |
ANG-(1–7) (10−9 M) | 203 ± 3* | 6 |
ANG-(1–7) (10−6 M) | 153 ± 8* | 5 |
A779 (10−6 M) | 126 ± 2* | 5 |
ANG-(1–7) (10−12 M) + A779 | 114 ± 7† | 5 |
ANG-(1–7) (10−9 M) + A779 | 96 ± 4† | 5 |
ANG-(1–7) (10−6 M) + A779 | 105 ± 5† | 5 |
BAPTA (5 × 10−5 M) | 58 ± 3* | 5 |
BAPTA + ANG-(1–7) (10−9 M) | 106 ± 3† | 5 |
BAPTA + ANG-(1–7) (10−6 M) | 82 ± 2*† | 6 |
Thapsigargin (10−5 M) | 341 ± 9* | 5 |
Thapsigargin + ANG-(1–7) (10−9 M) | 356 ± 9*† | 5 |
Thapsigargin + ANG-(1–7) (10−6 M) | 342 ± 12*† | 5 |
Values are the means ± SE; n = number of tubules (each tubule corresponds to the average of 10 areas). [Ca2+]i, intracellular Ca2+ concentration.
P < 0.01 vs. control;
P < 0.01 vs. ANG-(1–7) alone in the respective dose.